JP2025525370A5 - - Google Patents

Info

Publication number
JP2025525370A5
JP2025525370A5 JP2024574809A JP2024574809A JP2025525370A5 JP 2025525370 A5 JP2025525370 A5 JP 2025525370A5 JP 2024574809 A JP2024574809 A JP 2024574809A JP 2024574809 A JP2024574809 A JP 2024574809A JP 2025525370 A5 JP2025525370 A5 JP 2025525370A5
Authority
JP
Japan
Prior art keywords
group
alkyl groups
independently selected
groups
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024574809A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025525370A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CN2023/101737 external-priority patent/WO2023246872A1/zh
Publication of JP2025525370A publication Critical patent/JP2025525370A/ja
Publication of JP2025525370A5 publication Critical patent/JP2025525370A5/ja
Pending legal-status Critical Current

Links

JP2024574809A 2022-06-24 2023-06-21 Taar1リガンドアゴニストとしての複素環式化合物 Pending JP2025525370A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
CN202210723387 2022-06-24
CN202210723387.8 2022-06-24
CN202310089008 2023-02-09
CN202310089008.9 2023-02-09
PCT/CN2023/101737 WO2023246872A1 (zh) 2022-06-24 2023-06-21 作为taar1配体激动剂的杂环化合物

Publications (2)

Publication Number Publication Date
JP2025525370A JP2025525370A (ja) 2025-08-05
JP2025525370A5 true JP2025525370A5 (https=) 2026-04-14

Family

ID=89379183

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024574809A Pending JP2025525370A (ja) 2022-06-24 2023-06-21 Taar1リガンドアゴニストとしての複素環式化合物

Country Status (8)

Country Link
US (1) US20250382306A1 (https=)
EP (1) EP4545534A1 (https=)
JP (1) JP2025525370A (https=)
KR (1) KR20250028295A (https=)
CN (1) CN119403809A (https=)
AU (1) AU2023287274A1 (https=)
CA (1) CA3260200A1 (https=)
WO (1) WO2023246872A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025131045A1 (zh) * 2023-12-22 2025-06-26 山东绿叶制药有限公司 一种taar1配体激动剂的盐型、晶型及其制备方法和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG10201510665WA (en) * 2009-12-04 2016-01-28 Sunovion Pharmaceuticals Inc Multicycle Compounds And Pharmaceutical Compositions Useful For The Treatment Of Neurological Disorders
WO2022204150A1 (en) * 2021-03-22 2022-09-29 Blue Oak Pharmaceuticals, Inc. Compounds and compositions for treating cns disorders
CN115433205A (zh) * 2021-06-03 2022-12-06 上海翰森生物医药科技有限公司 多环类衍生物受体激动剂、其制备方法和应用

Similar Documents

Publication Publication Date Title
CN1529595A (zh) 具有效cb1-拮抗活性的4,5-2氢-1h-吡唑衍生物
AU2015361018B2 (en) 3-oxo-3-(arylamino)propanoates, a process for their preparation, and their use in preparing pyrrolidinones
JP2014515008A5 (https=)
JP2009531277A5 (https=)
JP2013512926A5 (https=)
JP2025525370A5 (https=)
JP2012530129A5 (https=)
RU2014145682A (ru) Органические соединения
JP2010529045A5 (https=)
JP2013519684A5 (https=)
CA2636324A1 (en) Cycloalkylamines as monoamine reuptake inhibitors
JP2011515482A5 (https=)
PH12012500951A1 (en) Substituted benzamide derivatives
JP2023535926A5 (https=)
JP2014527060A5 (https=)
JP2003530435A (ja) 一酸化窒素シンターゼ阻害剤として有用なハロゲン化2−アミノ−5,6−ヘプテン酸誘導体
JP2011517443A5 (https=)
JP2009527462A5 (https=)
CN102112465A (zh) 6-[(4s)-2-甲基-4-(2-萘基)-1,2,3,4-四氢异喹啉-7-基]哒嗪-3-胺的晶型
EP3180315A1 (en) Pyrazoles
JP2009528317A5 (https=)
NZ597498A (en) Cyclopropyl amine derivatives as histamin H3 receptor modulators
JP2023550543A5 (https=)
WO2017178343A1 (en) Novel n-[(pyrimidinylamino)propanyl]-and n-[(pyridinylamino)propanyl]arylcarboxamides
JP2014518212A5 (ja) 化合物及び組成物